Apelin-13 vs Catestatin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Apelin-13 is the most biologically active isoform of the apelin peptide family, endogenous ligands for the APJ receptor (also called APLNR). Apelin peptides are produced throughout the body, with the heart, lung, brain, and adipose tissue expressing particularly high levels....
Calculate Apelin-13 dose →Catestatin is a 21-amino acid peptide derived from the chromogranin A (CgA) protein, specifically cleaved from the region spanning residues 352-372. It was identified as an endogenous inhibitor of catecholamine secretion, acting as a non-competitive antagonist at nicotinic acetyl...
Calculate Catestatin dose →| Parameter | Apelin-13 | Catestatin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Clinical | Preclinical / Early Human |
| Half-Life | < 5 min (plasma) | ~15-30 minutes (IV) |
| Typical Dose | 50-300 nmol/kg | 0.3-3 nmol/kg (animal studies) |
| Frequency | Variable | Acute dosing in research |
| Route | Intravenous (research), Subcutaneous | IV (research); intranasal under study |
| FDA Status | Not approved | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.